• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536; PubMed=15816541).
  

PubMed=3063073; DOI=10.1007/978-3-7091-8978-8_23
Westphal M., Hansel M., Nausch H., Rohde E., Koppen J., Fiola M., Holzel F., Herrmann H.-D.
Glioma biology in vitro: goals and concepts.
Acta Neurochir. Suppl. (Wien) 43:107-113(1988)

PubMed=8253536; DOI=10.1002/ijc.2910550618
Anker L., Ohgaki H., Ludeke B.I., Herrmann H.-D., Kleihues P., Westphal M.
p53 protein accumulation and gene mutations in human glioma cell lines.
Int. J. Cancer 55:982-987(1993)

PubMed=8289093; DOI=10.1007/BF01324703
Hamel W., Westphal M., Shepard H.M.
Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease.
J. Neurooncol. 16:159-165(1993)

PubMed=8154317; DOI=10.1007/BF01476489
Westphal M., Hansel M., Hamel W., Kunzmann R., Holzel F.
Karyotype analyses of 20 human glioma cell lines.
Acta Neurochir. (Wien) 126:17-26(1994)

PubMed=16696057; DOI=10.1136/mp.49.2.M91; PMCID=PMC408028
Li W.-X., Martinerie C., Zumkeller W., Westphal M., Perbal B.
Differential expression of novH and CTGF in human glioma cell lines.
Clin. Mol. Pathol. 49:M91-M97(1996)

DOI=10.1007/0-306-46861-1_11
Ali-Osman F.
Brain tumors.
(In book chapter) Human cell culture. Vol. 2. Cancer cell lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.167-184; Kluwer Academic Publishers; New York; USA (1999)

PubMed=15816541
Kim E.L., Yoshizato K., Kluwe L., Meissner H., Warnecke G., Zapf S., Westphal M., Deppert W., Giese A.
Comparative assessment of the functional p53 status in glioma cells.
Anticancer Res. 25:213-224(2005)